Cancer-Associated Fibroblasts: Their Characteristics and Their Roles in Tumor Growth
Open accessThe DOI matches its Crossref record; 122 of the 125 references it cites were found in a registry or an index.
Abstract
Cancer tissues are composed of cancer cells and the surrounding stromal cells (e.g., fibroblasts, vascular endothelial cells, and immune cells), in addition to the extracellular matrix. Most studies investigating carcinogenesis and the progression, invasion, metastasis, and angiogenesis of cancer have focused on alterations in cancer cells, including genetic and epigenetic changes. Recently, interactions between cancer cells and the stroma have attracted considerable attention, and increasing evidence has accumulated on this. Several researchers have gradually clarified the origins, features, and roles of cancer-associated fibroblasts (CAFs), a major component of the cancer stroma. CAFs function in a similar manner to myofibroblasts during wound healing. We previously reported the relationship between CAFs and angiogenesis. Interleukin-6 (IL-6), a multifunctional cytokine, plays a central role in regulating inflammatory and immune responses, and important roles in the progression, including proliferation, migration, and angiogenesis, of several cancers. We showed that CAFs are an important IL-6 source and that anti-IL-6 receptor antibody suppressed angiogenesis and inhibited tumor-stroma interactions. Furthermore, CAFs contribute to drug-resistance acquisition in cancer cells. The interaction between cancer cells and the stroma could be a potential target for anti-cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, recent studies indicated that CAFs consist of several types of stromal cells that differ in their origin, functions, number, and phenotype [21, 22, 23, 24].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [21]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
IL-6 secreted by cancer-associated fibroblasts induces tamoxifen resistance in luminal breast cancer
Sun, X., Mao, Y., Wang, J., Zu, L., Hao, M., Cheng, G., Qu, Q., Cui, D., Keller, E. T., Chen, X., et al. (2014) · Oncogene · doi:10.1038/onc.2014.158 · Cited by 75
RetractedSun, X., Mao, Y., Wang, J., Zu, L., Hao, M., Cheng, G., Qu, Q., Cui, D., Keller, E. T., CHEN, X., et al. (2014) · Oncogene · doi:10.1038/onc.2014.224 · Cited by 40
RetractedChen, L., Qu, C., Chen, H., Xu, L., Qi, Q., Luo, J., Wang, K., Meng, Z., Chen, Z., Wang, P., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096177 · Cited by 30
RetractedWarburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425 · cited 1×
“This phenomenon is known as “Warburg effect” [84].”
BackgroundThe distribution of secondary growths in cancer of the breast.
Paget, S. (1889) · The Lancet · doi:10.1016/s0140-6736(00)49915-0 · Cited by 5,277
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391 · cited 1×
“proposed the theory that a “tumor is a wound that never heals” [2].”
BackgroundThe Biology of Vascular Endothelial Growth Factor
Ferrara, N., & Davis-Smyth, T. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0287 · Cited by 4,330
Myofibroblasts and mechano-regulation of connective tissue remodelling
Tomasek, J. J., Gabbiani, G., Hinz, B., Chaponnier, C., & Brown, R. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm809 · Cited by 4,290 · cited 2×
“These myofibroblasts acquire de novo expressed α-SMA, contractile stress fibers, and the ED-A splice variant of fibronectin [5,7].”
BackgroundComplex networks orchestrate epithelial–mesenchymal transitions
Thiery, J. P., & Sleeman, J. P. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1835 · Cited by 3,958
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Cited by
Items 501–600 of 814
Chen, S., McMiller, T. L., Soni, A., Succaria, F., Sidhom, J.-W., Cappelli, L. C., Casciola-Rosen, L. A., Morales, I. R., Sankaran, P., Berger, A. E., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-04973-7 · Cited by 13
Yap, N. Y., Ong, T. A., Morais, C., Pailoor, J., Gobe, G. C., & Rajandram, R. (2019) · Cell Biology International · doi:10.1002/cbin.11150 · Cited by 12
Grissenberger, S., Riedl, S., Rinner, B., Leber, R., & Zweytick, D. (2020) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2020.183264 · Cited by 12
Long Noncoding RNA: Shining Stars in the Immune Microenvironment of Gastric Cancer
Xiao, X. M., Cheng, W., Zhang, G., Wang, C., Sun, B., Zha, C., Kong, F., & Jia, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.862337 · Cited by 13
Nasr, M., Farghaly, M., Elsaba, T. M., El‐Mokhtar, M. A., Radwan, R., Elsabahy, M., Abdelkareem, A., Fakhry, H., & Mousa, N. A. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2018.10.005 · Cited by 13
Das, D., Fayazzadeh, E., Li, X., Koirala, N., Wadera, A., Lang, M., Zernic, M., Panick, C. E. P., Nesbitt, P., & McLennan, G. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29545 · Cited by 12
Integrative microphysiological tissue systems of cancer metastasis to the liver
Clark, A. M., Allbritton, N. L., & Wells, A. H. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.06.010 · Cited by 13
Sex-Based Differences in the Tumor Microenvironment
Wuidar, V., Gillot, L., Silva, I. D. D., Lebeau, A., Gallez, A., & Péqueux, C. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-73119-9_23 · Cited by 11
Serrero, G. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-73119-9_22 · Cited by 12
Fibroblasts mediate the angiogenesis of pheochromocytoma by increasing COX4I2 expression
Mao, Y., Zhuo, R., Ma, W., Dai, J., Alimu, P., Chen, F., Xu, D., Ye, L., Wang, W., & Sun, F. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.938123 · Cited by 11
Zhang, L., Xu, C., Wang, S., Ge, Q., Wang, X., Xiao, P., & Yao, Q. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.1054152 · Cited by 11
Chopra, S., Walia, R., Mathur, Y., Roesch, F., Moon, E. S., Rana, N., Pandey, S., Chatterji, D., Kumar, R., Singh, H., et al. (2023) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000004563 · Cited by 11
Fibroblast activation protein: Pivoting cancer/chemotherapeutic insight towards heart failure
Gehris, J., Ervin, C., Hawkins, C., Womack, S. J., Churillo, A. M., Doyle, J., Sinusas, A. J., & Spinale, F. G. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115914 · Cited by 11
Mechanisms of Gastrointestinal Malignancies
Katona, B. W., & Lynch, J. P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809954-4.00066-9 · Cited by 13
Rahmanzade, R. (2019) · Medical Hypotheses · doi:10.1016/j.mehy.2019.109425 · Cited by 11
Li, C., Liu, H., & Gong, Z. (2022) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2022.23.7.2199 · Cited by 11
Dieters‐Castator, D. Z., Dantonio, P. M., Piaseczny, M., Zhang, G., Liu, J., Kuljanin, M., Sherman, S. E., Jewer, M., Quesnel, K., Kang, E. Y., et al. (2021) · Neoplasia · doi:10.1016/j.neo.2021.02.004 · Cited by 11
Targeted therapy of tumour microenvironment by gold nanoparticles as a new therapeutic approach
Mahhengam, N., Kazemnezhad, K., Budi, H. S., Ansari, M. J., Bokov, D. O., Suksatan, W., Thangavelu, L. P., & Siahmansouri, H. (2022) · Journal of drug targeting · doi:10.1080/1061186x.2022.2032095 · Cited by 12
Commentary on Some Recent Theses Relevant to Combating Aging: February 2017
Zealley, B., & de Grey, A. D. N. J. (2017) · Rejuvenation Research · doi:10.1089/rej.2017.1925 · Cited by 11
Fan, J., Chen, Y., Gong, Y., Sun, H., Hou, R., Dou, X., Zhang, Y., & Huo, C. (2025) · Scientific Reports · doi:10.1038/s41598-025-93916-3 · Cited by 12
Roles of phenotypic heterogeneity and microenvironment feedback in early tumor development
Smart, M., Goyal, S., & Zilman, A. (2021) · Physical review. E · doi:10.1103/physreve.103.032407 · Cited by 12
Cancer Metastases to the Liver: Mechanisms of Tumor Cell Colonization
Andryszkiewicz, W., Misiąg, P., Karwowska, A., Resler, Z., Wojno, A., Kulbacka, J., Szewczyk, A., & Rembiałkowska, N. (2024) · Pharmaceuticals · doi:10.3390/ph17091251 · Cited by 11
Targeting the lung tumour stroma: harnessing nanoparticles for effective therapeutic interventions
Zhang, S., & Wang, H. (2024) · Journal of drug targeting · doi:10.1080/1061186x.2024.2410462 · Cited by 10
Core/shell multicellular spheroids on chitosan as in vitro 3D coculture tumor models
Tsai, C.-W., Wang, J., & Young, T. (2018) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2018.1505744 · Cited by 12
Ye, C., Li, W., Yu, H.-H., Feng, Q.-P., Wu, X., Zhu, Y., Hu, M., Xiang, S.-Y., & Yu, S. (2020) · Materials Science and Engineering C · doi:10.1016/j.msec.2020.111370 · Cited by 11
Li, F., Mao, C., Yeh, S., Xin, J., Wang, P., Shi, Q., & Ming, X. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.122076 · Cited by 10
Berndt, A., Gaßler, N., & Franz, M. (2022) · Cancers · doi:10.3390/cancers14194903 · Cited by 10
Circulating circRNA: a social butterfly in tumors
Miao, S., & Zhang, Q. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1203696 · Cited by 10
Zu, T., Wen, J., Xu, L., Li, H., Mi, J., Brakebusch, C., Fisher, D. E., & Wu, X. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00624 · Cited by 11
[Treatment with ramelteon for sleep disturbance in severely disabled children and young adults].
Miyamoto, A., Fukuda, I., Tanaka, H., Oka, R., Araki, A., & Cho, K. (2013) · PubMed · Cited by 16
Xie, M., Liang, L., Yu, L., Shi, J., Lei, Y., Huang, J., & Cai, X. (2024) · Translational Cancer Research · doi:10.21037/tcr-23-1484 · Cited by 9
Immune Regulation and Immune Therapy in Melanoma: Review with Emphasis on CD155 Signalling
Wu, L., Park, S.-H., Jakobsson, H., Shackleton, M. J., & Möller, A. (2024) · Cancers · doi:10.3390/cancers16111950 · Cited by 10
Characterization of Pancreatic and Biliary Cancer Stem Cells in Patient-derived Tissue
Gogolok, J., Seidel, E., Strönisch, A., Reutzel‐Selke, A., Sauer, I. M., Pratschke, J., Bahra, M., & Schmuck, R. B. (2020) · Anticancer Research · doi:10.21873/anticanres.14068 · Cited by 9
Nobari, S., Najafi, R., Mahdavinezhad, A., Jalali, A., & Amini, R. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/9369328 · Cited by 9
Nihashi, Y., Song, X., Yamamoto, M., Setoyama, D., & Kida, Y. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241311015 · Cited by 9
Sun, L., Jiang, Y., Tan, H. S., & Liang, R. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.128018 · Cited by 11
Cancer mechanobiology: interaction of biomaterials with cancer cells
Libring, S., & Solorio, L. (2020) · Elsevier eBooks · doi:10.1016/b978-0-08-102983-1.00016-8 · Cited by 10
Autophagy and ncRNAs: Dangerous Liaisons in the Crosstalk between the Tumor and Its Microenvironment
Eng, G. W. L., Zheng, Y., Yap, D. W. T., Teo, A. Y. T., & Cheong, J. K. (2021) · Cancers · doi:10.3390/cancers14010020 · Cited by 10
ERα36-High Cancer-Associated Fibroblasts as an Unfavorable Factor in Triple-Negative Breast Cancer
Nagel, A. C., Popęda, M., Muchlińska, A., Sądej, R., Szade, J., Zieliński, J., Skokowski, J., Niemira, M., Kretowski, A. J., Markiewicz, A., et al. (2022) · Cancers · doi:10.3390/cancers14082005 · Cited by 10
Ahmed, H., Ghoshal, A., Jones, S., Ellis, I., & Islam, M. R. (2020) · Cancers · doi:10.3390/cancers12082093 · Cited by 10
Altered Calcium Influx Pathways in Cancer-Associated Fibroblasts
Sadras, F., Stewart, T. A., Robitaille, M., Peters, A. A., Croft, P. K., Soon, P., Saunus, J. M., Lakhani, S. R., Roberts‐Thomson, S. J., & Monteith, G. R. (2021) · Biomedicines · doi:10.3390/biomedicines9060680 · Cited by 10
Microfluidic Applications in Prostate Cancer Research
Szewczyk, K., Jiang, L., Khawaja, H., Miranti, C. K., & Zohar, Y. (2024) · Micromachines · doi:10.3390/mi15101195 · Cited by 9
Lu, F., Yan, G., Zhao, Z., Zheng, Z., Wu, Y., Wen, L., Liu, Y., Zeng, Q., & Zhang, G. (2025) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-024-03921-0 · Cited by 8
Xiang, Y., Zhang, L., Ye, J., Chen, Y., Ren, Q., Su, B., Xu, X., & Zhang, Q. (2026) · Journal of Advanced Research · doi:10.1016/j.jare.2026.03.011 · Cited by 8
Huang, L., Hsieh, T.-M., Huang, C.-Y., Liu, Y., Wu, S., Chien, P., & Hsieh, C. (2021) · Genes · doi:10.3390/genes12081274 · Cited by 8
Identification of Breast Cancer Subtypes Based on Gene Expression Profiles in Breast Cancer Stroma
Uddin, M. N., & Wang, X. (2022) · Clinical Breast Cancer · doi:10.1016/j.clbc.2022.04.001 · Cited by 9
Cancer-associated immune cells and their modulation by melatonin
Hekmatirad, S., Moloudizargari, M., Fallah, M., Rahimi, A., Poortahmasebi, V., & Asghari, M. H. (2023) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2023.2239489 · Cited by 10
Ai, W., Liu, T., Lv, C., Feng, X., & Wang, Q. (2023) · Nanomedicine · doi:10.2217/nnm-2023-0088 · Cited by 8
The emergence of solid stress as a potent biomechanical marker of tumour progression
Vella, A., Eko, E. M., & Hernández, A. E. D. R. (2018) · Emerging Topics in Life Sciences · doi:10.1042/etls20180049 · Cited by 11
Effects of Nicotinamide on Cervical Cancer-Derived Fibroblasts: Evidence for Therapeutic Potential
Hassan, R. N., Luo, H., & Jiang, W. (2020) · Cancer Management and Research · doi:10.2147/cmar.s229395 · Cited by 8
Yabe, K., Yamamoto, Y., Takemura, M., Hara, T., Tsurumi, H., Serrero, G., Nabeshima, T., & Saito, K. (2021) · Heliyon · doi:10.1016/j.heliyon.2020.e05849 · Cited by 9
Borzdziłowska, P., & Bednarek, I. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23168913 · Cited by 10
Preoperative serum inflammation-based scores in medullary thyroid cancer
Figueiredo, A. A., Esteves, S., Moura, M. M., Marques, P., Simões‐Pereira, J., & Leite, V. A. P. H. (2023) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2022.06.015 · Cited by 8
Cancer-associated fibroblasts and their significance in tumor progression
Oleynikova, N. A., Danilova, N. V., Mikhailov, I. А., Semina, E. V., & Malkov, P. G. (2020) · Russian Journal of Archive of Pathology · doi:10.17116/patol20208201168 · Cited by 8
Pele, K. G., Calderón-Villalba, A., Amaveda, H., Mora, M., Zhang-Zhou, J., Pérez, M. Á., García‐Aznar, J. M., Alamán‐Díez, P., & García‐Gareta, E. (2025) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2025.114736 · Cited by 7
Naz, Z., Fareed, M., Snigdha, N. T., Zafar, A., Alsaidan, O. A., Aslam, M., Mangu, K., Neogi, K., Ahmad, S., & Rizwanullah, M. (2025) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.70040 · Cited by 7
Saifullah, Q., Mondal, S., Nandi, A., Yeduvaka, M., Das, S., & Roy, P. (2026) · Nanoscale Advances · doi:10.1039/d5na00907c · Cited by 8
Gromek, P., Senkowska, Z., Płuciennik, E., Pasieka, Z. W., Zhao, L.-Y., Gielecińska, A., Kciuk, M., Kłosiński, K. K., Kałuzińska‐Kołat, Ż., & Kołat, D. (2024) · World Journal of Methodology · doi:10.5662/wjm.v14.i2.92982 · Cited by 10
Luo, Y., Zhang, P., Wu, Z., Zou, L., Bai, X., Li, X., Gan, W., Wang, F., Han, Z., Lin, Q., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c00132 · Cited by 7
Tumorous CD10 Is More Strongly Related to the Progression of Urothelial Carcinoma than Stromal CD10
Kumagai, A., Uozaki, H., Kikuchi, Y., Watabe, S., Numakura, S., & Watanabe, M. (2019) · Anticancer Research · doi:10.21873/anticanres.13157 · Cited by 7
Radaei, Z., Zamani, A., Najafi, R., Saidijam, M., Jalilian, F. A., Ezati, R., Solgi, G., & Amini, R. (2020) · Current Medical Science · doi:10.1007/s11596-020-2289-7 · Cited by 7
Kudo, A., Yoshimoto, S., Yoshida, H., IZUMI, Y., & Takagi, S. (2022) · Journal of Veterinary Medical Science · doi:10.1292/jvms.22-0041 · Cited by 7
Geostatistical Modeling and Heterogeneity Analysis of Tumor Molecular Landscape
Hajihosseini, M., Amini, P., Voicu, D., Dinu, I. A., & Pyne, S. (2022) · Cancers · doi:10.3390/cancers14215235 · Cited by 9
Huli�k, I., Bodai, L., Czep�n, M., Kov�cs, D., Szab�, A., Tiszlavicz, L., L�z�r, G., Rakonczay, Z., ter Hegyi, P., Boros, I., et al. (2018) · Oncology Reports · doi:10.3892/or.2018.6909 · Cited by 7
Cancer Selective Turn-On Fluorescence Imaging Using a Biopolymeric Nanocarrier
Jeong, Y., Kim, G., Jeong, S., Lee, B., Kim, S., Koh, W., & Lee, K. (2019) · Biomacromolecules · doi:10.1021/acs.biomac.8b01690 · Cited by 8
Computational modelling in single-cell cancer genomics: methods and future directions
Zhang, A. W., & Campbell, K. R. (2020) · Physical Biology · doi:10.1088/1478-3975/abacfe · Cited by 7
Naleskina, L. A., Kunska, L. M., & Chekhun, V. F. (2023) · Experimental Oncology · doi:10.32471/exp-oncology.2312-8852.vol-42-no-4.15401 · Cited by 9
Thongchot, S., Jamjuntra, P., Prasopsiri, J., Thuwajit, P., Sawasdee, N., Poungvarin, N., Warnnissorn, M., Sa-nguanraksa, D., O‐charoenrat, P., Yenchitsomanus, P., et al. (2021) · Oncology Reports · doi:10.3892/or.2021.8205 · Cited by 7
Interaction of lncRNAs with mTOR in colorectal cancer: a systematic review
Moslehian, M. S., Shabkhizan, R., Asadi, M. R., Bazmani, A., Mahdipour, M., Haiaty, S., Rahbarghazi, R., & Sakhinia, E. (2023) · BMC Cancer · doi:10.1186/s12885-023-11008-9 · Cited by 8
Bracigliano, A., Clemente, O., Peddio, A., Scarpati, G. D. V., Pizzolorusso, A., Cannella, L., Picozzi, F., Garosi, C., Papa, F., Balzamo, F., et al. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104852 · Cited by 6
Chen, S., Chang, K., Hou, C., Lin, W.-Y., Hsu, S.-Y., Sung, H., Feng, T., Lin, Y.-H., & Juang, H. (2026) · Translational Oncology · doi:10.1016/j.tranon.2026.102680 · Cited by 6
Mohamed, D., & Safia, H. S. A. (2020) · International Journal of Cancer and Biomedical Research · doi:10.21608/jcbr.2020.26388.1020 · Cited by 6
Role of cancer-associated fibroblasts in tumor microenvironment
Mir, M. A., Sofi, S., & Aisha, S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-443-18696-7.00002-6 · Cited by 6
Amini, P., Hajihosseini, M., Pyne, S., & Dinu, I. A. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1065586 · Cited by 6
Liu, J., Sun, Z., Cao, S., Dai, H., Zhang, Z., Luo, J., & Wang, X. (2025) · BMC Oral Health · doi:10.1186/s12903-024-05284-5 · Cited by 6
Zhang, W., Li, Y., Li, C., & Huang, Q. (2025) · Hereditas · doi:10.1186/s41065-025-00548-8 · Cited by 6
Aguilera‐Rojas, M., Sharbati, S., Stein, T., & Einspanier, R. (2020) · FEBS Open Bio · doi:10.1002/2211-5463.12831 · Cited by 8
Epithelial to Mesenchymal Transition
Dalton, A. C., & Howe, P. H. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00005-0 · Cited by 6
Parvaneh, S., Miklós, V., Páhi, Z. G., Szűcs, D., Monostori, T., Póliska, S., Venglovecz, V., Pankotai, T., Kemény, L. V., & Veréb, Z. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26010390 · Cited by 6
Jafari, B., Hamzeh‐Mivehroud, M., Morris, M. B., & Dastmalchi, S. (2019) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2019.03.002 · Cited by 6
Khuda‐Bukhsh, A. R., Saha, S. K., Das, S., & Saha, S. S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819547-5.00018-3 · Cited by 6
Torres‐García, W., & Domenech, M. (2017) · Molecular BioSystems · doi:10.1039/c7mb00416h · Cited by 6
Review and Prospect of Tissue-agnostic Targeted Strategies in Anticancer Therapies
Peng, Y., Tao, H., Gao, Y., Yang, Y., & Chen, Z. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200616143247 · Cited by 7
HIFU induces reprogramming of the tumor immune microenvironment in a pancreatic cancer mouse model
Yamaguchi, T., Kitahara, S., Matsui, A., Okamoto, J., Muragaki, Y., & Masamune, K. (2025) · Medical Molecular Morphology · doi:10.1007/s00795-025-00419-1 · Cited by 5
Zhou, J.-B., Li, C., Qian, L., & Chu, J.-H. (2025) · Computer Methods in Biomechanics & Biomedical Engineering · doi:10.1080/10255842.2025.2495299 · Cited by 5
Tan, J., Wu, Z., Liu, Y., Wang, W., Qin, W., Pan, G., Xiong, Y., Ma, J., Zhao, J., Zhou, H., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1592558 · Cited by 5
Wang, R., Qin, G.-H., Jiang, Y., Chen, F., Wang, Z., Ju, L., Chen, L., Fu, D., Liu, E., Zhang, S., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1592416 · Cited by 5
Wang, X., Zou, R., Yang, N., Huang, W., Wang, C., Huang, Y., Chen, Y., Wang, D., Ren, G., & Yao, D. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.5c00951 · Cited by 5
Is There a Role of FAPI Pet in Renal and Bladder Cancer?
Filippi, L., Mass, A. C. L., Arslan, E., Alçın, G., Guglielmo, P., & Evangelista, L. (2025) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2025.11.003 · Cited by 5
Emran, T. B., Amin, M. A., Rab, S. O., Jahnavi, P., Vodeti, R., Gupta, J. K., Arjun, U. V. N. V., Umamaheswari, T. N., Balaji, P., Dayalan, G., et al. (2025) · 3 Biotech · doi:10.1007/s13205-025-04651-5 · Cited by 5
Chi, H., Chen, D., Zhang, Y., Cui, Z., Bai, Y., & Zhang, Y. (2023) · iLiver · doi:10.1016/j.iliver.2022.12.002 · Cited by 5
Thomas, A., Pathak, N., Moses, L., & Munirathinam, G. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-13212-4.00002-7 · Cited by 5
Longmate, W. M. (2024) · Matrix Biology · doi:10.1016/j.matbio.2024.11.002 · Cited by 5
Newnes, H. V., Armitage, J. D., Audsley, K. M., Bosco, A., & Waithman, J. C. (2021) · Cancers · doi:10.3390/cancers13235911 · Cited by 5
Cellular microenvironment as an object of targeted therapy for malignant neoplasms
Zyablitskaya, E. Y., Kubyshkin, A. V., Sorokina, L. E., Serebryakova, A. V., Aliev, K. A., Maksimova, P. E., Lazarev, A. E., Balakchina, A. I., & Golovkin, I. O. (2023) · Advances in molecular oncology · doi:10.17650/2313-805x-2023-10-4-8-20 · Cited by 6
Battista, D. D., Yakymi, R., Scheibe, E., Sato, S., Gerstein, H., Markowitz, T. E., Lack, J., Mereu, R., Manieli, C., Zamboni, F., et al. (2024) · Cancers · doi:10.3390/cancers16071370 · Cited by 6
Chopra, S., Mathur, Y., Roesch, F., Moon, E. S., Singh, H., Kalra, N., Duseja, A. K., Mittal, B. R., & Shukla, J. (2024) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000005391 · Cited by 5
Novel approaches to promote CAR T-cell function in solid tumors
Hull, C., & Maher, J. F. (2019) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2019.1614164 · Cited by 5
Li, Y., Luo, Y., Li, X., Huang, Z., & Wang, Y. (2021) · Smart Materials in Medicine · doi:10.1016/j.smaim.2021.08.004 · Cited by 5
Leighow, S. M., Landry, B. D., Lee, M. J., Peyton, S. R., & Pritchard, J. R. (2022) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-022-00748-6 · Cited by 5
Metadata
- Authors
- Shiga, K., Hara, M., Nagasaki, T., Sato, T., Takahashi, H., & Takeyama, H.
- Affiliations
- Nagoya City University (JP)
- Corresponding author
- Hara, Masayasu
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2015-12-11
- Volume
- 7
- Issue
- 4
- Pages
- 2443-2458
- ISSN
- 2072-6694 (ISSN-L)
- PMC
- PMC4695902
- OpenAlex
- W2190528488
- Cited by
- 774
- References
- 125
- Citations by year
- 2026: 29 · 2025: 42 · 2024: 61 · 2023: 71 · 2022: 83 · 2021: 103 · 2020: 121 · 2019: 104 · 2018: 87 · 2017: 49 · 2016: 21
- FWCI
- 5.63
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Cancers (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- cancer-associated fibroblasts, tumor microenvironment, tumor stroma, tumor-stroma interactions, angiogenesis, interleukin-6, IL-6 receptor, myofibroblasts, drug resistance, tumor progression, cancer therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.